The influence of binazin on the levels of biogenic amines in the brain, heart, kidneys, and aorta of the experimental animals.
D000818:Animals; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001011:Aorta / Q000032:analysis*; D001679:Biogenic Amines / Q000032:analysis*; D001923:Brain Chemistry / Q000187:drug effects*; D002264:Carboxylic Acids / Q000008:administration & dosage / Q000494:pharmacology; D003864:Depression, Chemical; D004298:Dopamine / Q000032:analysis; D005260:Female; D006834:Hydrazines / Q000008:administration & dosage / Q000494:pharmacology*; D006897:Hydroxyindoleacetic Acid / Q000032:analysis; D007668:Kidney / Q000032:analysis*; D008297:Male; D009206:Myocardium / Q000032:analysis*; D009638:Norepinephrine / Q000032:analysis; D010793:Phthalazines / Q000008:administration & dosage / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012701:Serotonin / Q000032:analysis
D000959:Antihypertensive Agents; D001679:Biogenic Amines; D002264:Carboxylic Acids; D006834:Hydrazines; D010793:Phthalazines; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D004298:Dopamine; D009638:Norepinephrine